Law Firm Finkelstein Thompson LLP Announces Investigation of UPI Inc.


Law Firm Finkelstein Thompson LLP Announces Investigation of UPI Inc.

WASHINGTON--(BUSINESS WIRE)-- Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Uroplasty, Inc. ("Uroplasty" or the "Company") (NYS: UPI) . If you are interested in discussing your rights as a UPI shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at

On June 14, 2013, UPI announced that it would delay the filing of its Form 10-K for the fiscal year ending March 31, 2013 pending review of its internal control over financial reporting related to expense reimbursements and to the timing of the recognition of orders and the payment of sales commissions at the end of fiscal quarters. Simultaneously, UPI announced that it was placing its Chief Financial Officer, Medi A. Jiwani, on administrative leave until resolution of these issues.

On this news, UPI's share price declined by $.32 per share to $2.16 on June 14, 2013. Finkelstein Thompson's investigation focuses on what remedies shareholders may have against UPI or its board of directors.

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers. To learn more about Finkelstein Thompson LLP, please visit our web site at Attorney advertising. Prior results do not guarantee similar outcomes.

Finkelstein Thompson LLP
L. Kendall Satterfield, 877-337-1050

KEYWORDS: United States North America District of Columbia


The article Law Firm Finkelstein Thompson LLP Announces Investigation of UPI Inc. originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.